4893 items matching your search terms.

Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis

Simon, S. Francis, K. E. Dalrymple, J. E. Gebski, V. Lord, S. J. Friedlander, M. Lee, C. K.
EUROPEAN JOURNAL OF CANCER, 2022     DOI:10.1016/j.ejca.2022.04.022

Detailed analysis of in-hospital costs for adult patients with type III intestinal failure: A single-center study with global implications

Siu, A. H. Y. Carey, S. Jones, L. Morton, R. L. Koh, C. E.
JPEN: JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2022     DOI:10.1002/jpen.2136

PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL)

Steffens, D. Young, J. Riedel, B. Morton, R. Denehy, L. Heriot, A. Koh, C. Li, Q. Bauman, A. Sandroussi, C. Ismail, H. Dieng, M. Ansari, N. Pillinger, N. O'Shannassy, S. McKeown, S. Cunningham, D. Sheehan, K. Iori, G. Bartyn, J. Solomon, M.
BMC CANCER, 2022     DOI:10.1186/s12885-022-09492-6

B-Type natriuretic peptide and long-term cardiovascular mortality in patients with coronary heart disease

Stewart, R. A. H. Kirby, A. White, H. D. Marschner, S. L. West, M. Thompson, P. L. Sullivan, D. Janus, E. Hunt, D. Kritharides, L. Keech, A. Simes, J. Tonkin, A. M.
J AM HEART ASSOC, 2022     DOI:10.1161/JAHA.121.024616

Reply to L. Marandino et al

Stockler, M. R. Martin, A. J. Dhillon, H. M. Davis, I. D. Sweeney, C. J.
JOURNAL OF CLINICAL ONCOLOGY, 2022     DOI:10.1200/JCO.22.00497

Telomeres do not always shorten over time in individuals with type 1 diabetes

Syreeni, A. Carroll, L. M. Mutter, S. Januszewski, A. S. Forsblom, C. Lehto, M. Groop, P. H. Jenkins, A. J. FinnDiane Study, Group
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022     DOI:10.1016/j.diabres.2022.109926

Translating clinical trial evidence to routine practice-how do we overcome the barriers?

Tang, M. Lee, C. K.
JAMA ONCOL, 2022     DOI:10.1001/jamaoncol.2022.0038

Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer

Tang, M. Lee, C. K. Lewis, C. R. Boyer, M. Brown, B. Schaffer, A. Pearson, S. A. Simes, R. J.
LUNG CANCER, 2022     DOI:10.1016/j.lungcan.2022.01.024

Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma

Thompson, J. R. Smith, A. L. Lo, S. N. Kasparian, N. A. Saw, R. P. Dieng, M. Seaman, L. Martin, L. K. Guitera, P. Milne, D. Schmid, H. Cust, A. E. Bartula, I.
BMJ OPEN, 2022     DOI:10.1136/bmjopen-2021-054337

Common genetic variants do not predict recurrent events in coronary heart disease patients

Thompson, P. L. Hui, J. Beilby, J. Palmer, L. J. Watts, G. F. West, M. J. Kirby, A. Marschner, S. Simes, R. J. Sullivan, D. R. White, H. D. Stewart, R. Tonkin, A. M.
BMC CARDIOVASCULAR DISORDERS, 2022     DOI:10.1186/s12872-022-02520-0

Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer

Tjokrowidjaja, A. Lord, S. J. John, T. Lewis, C. R. Kok, P. S. Marschner, I. C. Lee, C. K.
CANCER, 2022     DOI:10.1002/cncr.34113

Cost analysis of adjuvant whole-brain radiotherapy treatment versus no whole-brain radiotherapy after stereotactic radiosurgery and/or surgery among adults with one to three melanoma brain metastases: results from a randomized trial

Tran, A. D. Hong, A. M. Nguyen, M. T. H. Fogarty, G. Steel, V. Paton, E. Morton, R. L.
PHARMACOECON OPEN, 2022     DOI:10.1007/s41669-022-00332-8

Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial

Tran, A. D. Hong, A. M. Nguyen, M. T. H. Fogarty, G. Steel, V. Paton, E. Morton, R. L.
PHARMACOECON OPEN, 2022     DOI:10.1007/s41669-022-00332-8

Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized phase III-trial AGITG-MAX

van Dijk, E. van Werkhoven, E. Asher, R. Mooi, J. K. Espinoza, D. van Essen, H. F. van Tinteren, H. van Grieken, N. C. T. Punt, C. J. A. Tebbutt, N. C. Ylstra, B.
INTERNATIONAL JOURNAL OF CANCER, 2022     DOI:10.1002/ijc.34061

A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol

Vatandoust, S. Wattchow, D. Sposato, L. Michael, M. Z. Leung, J. Gormly, K. Chen, G. Symonds, E. L. Tie, J. Papanicolas, L. E. Woods, S. Gebski, V. Mead, K. Kuruni, A. Karapetis, C. S.
BMC CANCER, 2022     DOI:10.1186/s12885-022-09304-x